Agency for Science, Technology and Research

Last updated

Agency for Science, Technology and Research
A*STAR logo.png
Agency overview
Formed11 January 1991;31 years ago (1991-01-11) (as National Science and Technology Board)
5 January 2002;20 years ago (2002-01-05) (as Agency for Science, Technology and Research)
Jurisdiction Government of Singapore
Headquarters1 Fusionopolis Way, #20-10 Connexis, Singapore 138632
Agency executives
  • Chan Lai Fung, Chairman
  • Frederick Chew, CEO
  • Suresh Sachi, Deputy Chief Executive (Corporate)
  • Andy Hor, Deputy Chief Executive (Research)
Parent agency Ministry of Trade and Industry
Website www.a-star.edu.sg

The Agency for Science, Technology and Research (A*STAR) is a statutory board under the Ministry of Trade and Industry of Singapore.

Contents

The agency supports R&D that is aligned to areas of competitive advantage and national needs for Singapore. These span the four technology domains of Manufacturing, Trade and Connectivity, Human Health and Potential, Urban Solutions and Sustainability, and Smart Nation and Digital Economy set out under the nation's five-year R&D plan (RIE2025). [1]

The agency's research institutes are located mostly in Biopolis and Fusionopolis. The total strength of the A*STAR community, including scientists and researchers, technical and non-technical staff, and industry development and commercialization staff is approximately at 5,400.

History

A*STAR was established on 11 January 1991. [2] It was formerly known as the National Science and Technology Board (NSTB) until January 2002.

On 29 October 2003, Singapore's hub for the biomedical sciences, Biopolis, was opened. A*STAR's biomedical research institutes and centres are located at Biopolis, along with other corporate research labs by companies such as Novartis, Danone, Abbott and Procter & Gamble. Over the years, the biomedical sector in Singapore has expanded in tandem with Biopolis. In 2000, the sector contributed 10 per cent to Singapore's manufacturing value-add. In April 2017, biomedical manufacturing was the second largest contributor to total manufacturing value-add at 19.6 per cent. [3]

Fusionopolis One was launched on 17 October 2008, adding a second R&D hub on physical sciences and engineering. The opening of Fusionopolis came as Singapore recorded its highest Gross Domestic Expenditure in R&D (GERD) of S$6.3 billion at that time in 2007. The amount was an unprecedented increase of 26 per cent from the 2006 GERD, and double the amount of S$3 billion recorded in 2000. [4]

On 19 October 2015, Fusionopolis Two was officially opened at the one-north precinct. Together with Fusionopolis One which was launched in 2008, the Fusionopolis cluster integrates all of A*STAR's science and engineering research capabilities and fosters close collaboration between the private and public sectors. The co-location of A*STAR's research institutes at Fusionopolis and Biopolis brings together researchers and industry partners to work closely on projects. [5]

The team from A*STAR helped set up and maintain the GISAID database storing and sharing COVID-19 virus data, including quality checking functions for genomic sequences sent in by various countries. [6]

A*STAR entities

The agency is made up of:

Industry engagement

Between 2011 – 2015, A*STAR worked on 8,965 industry projects, almost six times that of the previous five-year tranche of 1,547. This has resulted in more than S$1.6 billion in industry R&D spending. A*STAR also signed 1,030 licensing agreements over the same period, of which 70 per cent were signed with local SMEs. [8]

By aligning its research with industry demand, the agency has seeded collaborations with multi-national companies such as Rolls-Royce, Applied Materials, Inc., Procter & Gamble (P&G) and Chugai Pharmaceutical Co., Ltd.

In 2014, P&G opened its S$250 million Singapore Innovation Centre at Biopolis to support the company's product development in the areas of beauty, home care, as well as personal health and grooming, with research done here being incorporated into producing products for brands such as Pantene and SK-II. [9]

In October 2015, Applied Materials announced the opening of a new joint R&D laboratory with A*STAR. The five-year agreement included the opening of a S$150 million lab that would be located at Fusionopolis Two. The lab's research would focus primarily on developing advanced semiconductor technologies for use in future generations of logic and memory chips, found in smartphones and laptops. The collaboration with A*STAR marked the second time that Applied Materials has chosen to conduct product development and commercialisation activities outside its Santa Clara headquarters in the US. [10]

Future of manufacturing

To prepare Singapore's manufacturing industry for the future economy, A*STAR outlined its Future of Manufacturing (FoM) roadmap and initiatives at the Committee of Supply Debate 2017. [11]

A*STAR has implemented the Model Factory Initiative at two locations: ARTC and SIMTech.

A*STAR's ARTC would jointly conduct manpower training sessions with consulting firm McKinsey & Company to groom talent for jobs in advanced manufacturing technologies. These sessions cover areas such as predictive maintenance, digitised performance management, procurement and supply chain. [12]

SIMTech also signed MOUs with the Trade Associations and Chambers, the Singapore Precision Engineering and Technology Association (SPETA), and the Singapore Manufacturing Federation (SMF), to provide their members with training to deepen their manufacturing capabilities for the Future Economy. [13]

Beyond manufacturing

Food and Nutrition is an emerging sector in Singapore. One of Singapore's successes between 2011 and 2015 was in growing an R&D ecosystem for the F&N and consumer care sector. This has led to the creation of close to 1,000 new R&D jobs. [14] Leading nutrition companies such as Nestlé (Nestle Research Centre) and Danone (Nutricia Research) have either established new facilities or expanded existing ones in Biopolis, and are working closely with A*STAR to conduct R&D to develop healthier and safer products. [15]

Singapore's first publicly funded drug candidate, ETC-159, which was discovered and developed through a collaboration with Duke-NUS Graduate Medical School, advanced into Phase 1 clinical trials in July 2015. This drug targets a number of cancers, including colorectal, ovarian and pancreatic cancers, which contribute to a significant proportion of Singapore's cancer burden. [16]

A*STAR further announced that its second locally developed cancer drug, ETC-206, which targets blood cancers, has advanced to first-in-man trials in 2016. [17] A*STAR would also be building a centre for large molecules, known as the Experimental Biologics Centre (EBC). [18]

In 2016, A*STAR's commercialisation arm, A*ccelerate (formerly ETPL) opened the first-of-its-kind "open innovation lab" and the incubator known as A*START Central with 10 medtech, biotech and Internet start-ups on board. It can support up to 25 start-ups with conducive infrastructure, mentorship, funding and access to business networks. [19]

Related Research Articles

<span class="mw-page-title-main">National University of Singapore</span> Autonomous university in Singapore

The National University of Singapore (NUS) is a national research university in Singapore. Founded in 1905 as the Straits Settlements and Federated Malay States Government Medical School, NUS is the oldest autonomous university in the country. It offers degree programmes in a wide range of disciplines at both the undergraduate and postgraduate levels, including in the sciences, medicine and dentistry, design and environment, law, arts and social sciences, engineering, business, computing, and music.

<span class="mw-page-title-main">Defence Research and Development Organisation</span> Government agency in India

The Defence Research and Development Organisation (DRDO) is the premier agency under the Department of Defence Research and Development in Ministry of Defence of the Government of India, charged with the military's research and development, headquartered in Delhi, India. It was formed in 1958 by the merger of the Technical Development Establishment and the Directorate of Technical Development and Production of the Indian Ordnance Factories with the Defence Science Organisation. Subsequently, Defence Research & Development Service (DRDS) was constituted in 1979 as a service of Group 'A' Officers / Scientists directly under the administrative control of Ministry of Defence.

<span class="mw-page-title-main">Biopolis</span>

Biopolis is a research and development centre for biomedical sciences in Singapore. It is located at one-north in Buona Vista, and is close to the National University of Singapore, the Singapore Polytechnic, the Singapore Institute of Technology, the National University Hospital, the Singapore Science Park, Ministry of Education, ESSEC Business School, INSEAD Business School, and Fusionopolis. This campus is dedicated to providing space for biomedical research and development activities and promoting peer review and collaboration among the private and public scientific community.

<span class="mw-page-title-main">National University of Sciences & Technology</span> Public university in Islamabad, Pakistan

The National University of Sciences & Technology (NUST) is a multi-campus public research university having its main campus in Islamabad, Pakistan.

<span class="mw-page-title-main">Cooperative Research Centre</span> Australian scientific research programme

Cooperative Research Centres (CRCs) are an Australian Federal Government program and are key bodies for Australian scientific research. The Cooperative Research Centres Programme was established in 1990 to enhance Australia's industrial, commercial and economic growth through the development of sustained, user-driven, cooperative public-private research centres that achieve high levels of outcomes in adoption and commercialisation. The program emphasises the importance of collaborative arrangements to maximise the benefits of research through an enhanced process of utilisation, commercialisation, and technology transfer.

<span class="mw-page-title-main">Republic Polytechnic</span> Post-secondary academic institution in Singapore

Republic Polytechnic (RP) is a post-secondary education institution and statutory board under the purview of the Ministry of Education in Singapore.

<span class="mw-page-title-main">JTC Corporation</span> Singaporean agency for sustainable development

JTC Corporation (JTC), formerly the Jurong Town Corporation, is a statutory board under the Ministry of Trade and Industry that champions sustainable industrial development. It masterplans clean, green and smart estates to create attractive destinations for Singapore's talent and communities. The agency also drives innovations in the building and infrastructure sector.

<span class="mw-page-title-main">Genome Valley</span> Science Parks

Genome Valley is an Indian high-technology business district spread across 2,000-acre (8.1 km2) in Hyderabad, India. It is located across the suburbs, Turakapally, Shamirpet, Medchal, Uppal, Patancheru, Jeedimetla, Gachibowli and Keesara. The Genome Valley has developed as a cluster for Biomedical research, training and manufacturing. Genome Valley is now into its Phase III, which is about 11 kms from the Phase I and II with the total area approximately 2,000-acre (8.1 km2).

Miranda Yap was a professor in the Chemical and Biomolecular Engineering Department of the National University of Singapore, and the Executive Director of the Bioprocessing Technology Institute at the Agency for Science, Technology and Research of Singapore (A*STAR).

<span class="mw-page-title-main">Sree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum</span> Research Institute in India

Sree Chitra Tirunal Institute for Medical Sciences & Technology (SCTIMST), Trivandrum, is an Institution of National Importance established by an Act of Parliament in 1980. It is under the aegis of Department of Science and Technology, Government of India, with an Institute Body and a Governing Body constituted as per the provisions of the Sree Chitra Tirunal Institute for Medical Sciences & Technology, Trivandrum, Act, 1980. The Institute presents a unique model by connecting the different strands of Biomedical Technology ,Clinical Medicine and Public Health to produce a seamless continuum of indisputable relevance to society.

<span class="mw-page-title-main">Philip Yeo</span>

Noel Philip Yeo Liat Kok, DUNU , is the Chairman of Economic Development Innovations Singapore, Advanced MedTech Holdings and Accuron Technologies. From April 2007 to March 2018, Yeo was Chairman of Standards Productivity and Innovation for Growth, a government development agency with the mission to grow small and medium enterprises and startups.

one-north Subzone of Queenstown Planning Area in Central Region ----, Singapore

One-north is a subzone of Queenstown, Singapore, first developed by JTC Corporation as the country's research and development and high technology cluster. It was first conceptualised in 1991 as part of the National Technology Plan and officially launched on 4 December 2001 by then Deputy Prime Minister Tony Tan Keng Yam.

Fusionopolis is a research and development complex located at the one-north business park in Singapore. It houses various research organizations, high-tech companies, government agencies, retail outlets, and serviced apartments in one location.

<span class="mw-page-title-main">Science and technology in Malaysia</span>

Science policy in Malaysia is regulated by the Ministry of Science, Technology, and Innovation. The ministry focuses on five areas: biotechnology, ICT policy, industry, sea to space and core science and technology. Other ministries, such as the Ministry of Agriculture and the Ministry of Health also have science departments. Training in scientific areas was promoted during the 1970s and 1980s. From 1987-1997 research and development used 0.24% of GNP, and in 1998 high-tech exports made up 54% of Malaysia's manufactured exports.

McMaster Innovation Park is an innovation and research facility located approximately 2 kilometers from McMaster University in Hamilton, Ontario. McMaster Innovation Park's focuses on supporting startups, business, research through providing property management services as well as business aid. Entrepreneurs, firms, researchers, industry partners, business mentors and support facilities are the main customers of the firm. MIP currently houses four buildings: the Atrium@MIP, CanmetMATERIALS, McMaster Automotive Resource Centre (MARC), Biomedical Engineering and Advanced Manufacturing (BEAM) project centre and envisions 10 buildings on site within 10 years with 1,500–1,800 people working full-time.

Jackie Yi-Ru Ying is an American nanotechnology scientist based in Singapore. She is the founding executive director of the Institute of Bioengineering and Nanotechnology (IBN).

<span class="mw-page-title-main">Xian Jun Loh</span> Singaporean polymer chemist

Xian Jun Loh is a Singaporean polymer chemist who works in the inter-disciplinary field of biomaterials. He is the Executive Director of the Institute of Materials Research and Engineering of the Agency for Science, Technology and Research and a professor at the Nanyang Technological University. He is currently the Vice-President of the Singapore National Institute of Chemistry.

Science and technology in Uganda examines government efforts to develop a national innovation system and the impact of these policies.

<span class="mw-page-title-main">Lim Chwee Teck</span>

Chwee Teck (C.T.) Lim is a Singaporean scientist and entrepreneur. He is a specialist in human disease mechanobiology and in developing medical technologies for disease diagnosis and precision therapy and bringing them from the laboratory to the bedside.

<span class="mw-page-title-main">Teck-Seng Low</span> Singaporean engineer and academic administrator

Teck Seng Low is Malaysian-born Singaporean engineer and academic administrator. He was dean of engineering at the National University of Singapore, founding principal of Republic Polytechnic, and managing director of A*STAR before becoming chief executive officer of the National Research Foundation, Prime Minister's Office (Singapore). He returned to NUS in 2022 where he is currently Senior Vice President.

References

  1. ↑ "Record $25 billion for research and innovation over next 5 years to secure Singapore's future". Straits Times. 11 December 2020.
  2. ↑ Singapore, National Library Board. "Agency for Science, Technology and Research (A*STAR) | Infopedia". eresources.nlb.gov.sg. Retrieved 16 June 2017.
  3. ↑ "EDB Monthly Manufacturing Performance – April 2017" (PDF).
  4. ↑ "Singapore opens Fusionopolis, its second major R&D hub in 5 years, as its R&D expenditure hits S$6.3 billion > Agency for Science Technology and Research (A*STAR)". a-star.edu.sg. Retrieved 16 June 2017.
  5. ↑ "Fusionopolis Two to boost collaboration between private, public sectors". Channel NewsAsia. Retrieved 16 June 2017.
  6. ↑ Khalik, Salma (15 January 2021). "Punching above its weight in global fight against Covid-19". The Straits Times. Retrieved 12 September 2021.
  7. ↑ "THE 2000s". eresources.nlb.gov.sg. Retrieved 11 January 2022.
  8. ↑ Choudhury, Amit Roy. "A*Star surpasses 5-year targets; industry R&D spend exceeds S$1.6b". The Business Times. Retrieved 16 June 2017.
  9. ↑ "News - 2014 - P&G opens $250 million Innovation Centre". Singapore Economic Development Board - Investing Business in Singapore. Retrieved 16 June 2017.
  10. ↑ "Applied Materials, A*STAR to set up S$150m R&D lab". Channel NewsAsia. Retrieved 16 June 2017.
  11. ↑ "Speech by Mr S Iswaran, Minister for Trade and Industry (Industry), During the Committee of Supply Debate Under Head V". www.mti.gov.sg. Retrieved 1 November 2022.
  12. ↑ "New McKinsey centre aims to groom talent in advanced technologies". TODAYonline. Retrieved 19 June 2017.
  13. ↑ "New initiatives launched for precision engineering sector". Channel NewsAsia. Retrieved 19 June 2017.
  14. ↑ Choudhury, Amit Roy. "A*Star to set up two model plants as test beds for new tech and innovation (Amended)". The Business Times. Retrieved 19 June 2017.
  15. ↑ hermesauto (1 April 2016). "New Nestle research centre in Singapore to focus on nutrition for healthy ageing". The Straits Times. Retrieved 19 June 2017.
  16. ↑ "Made-in-Singapore cancer drug advances to clinical trials on humans". Channel NewsAsia. Retrieved 19 June 2017.
  17. ↑ hermesauto (9 March 2017). "Made-in-Singapore drug for blood cancer to be tested". The Straits Times. Retrieved 19 June 2017.
  18. ↑ Cheok, Jacquelyn. "A*Star to undergo major restructuring". The Business Times. Retrieved 19 June 2017.
  19. ↑ Cheok, Jacquelyn. "A*Star to launch Singapore's first open innovation lab". The Business Times. Retrieved 19 June 2017.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.